A global technology company was separating its hardware and software divisions into two independent business units. IP was deeply integrated across both, and the company needed…
A mid-cap ASX-listed biotech had completed Phase I clinical trials and was preparing a global roadshow to explore acquisition or licensing opportunities.
A US-domiciled multinational mining company was negotiating a joint venture with a small-cap Australian miner to develop a new metals processing technology.